**Core Concept**
Vitamin D deficiency is a common issue in many populations, and monitoring its treatment is crucial to ensure adequate correction of deficiency states. The best method for monitoring treatment and resolution involves assessing the levels of a specific metabolite that is directly related to the biologically active form of vitamin D.

**Why the Correct Answer is Right**
The best method for monitoring vitamin D treatment is by measuring the levels of 25-hydroxyvitamin D [25(OH)D], which is the primary circulating metabolite of vitamin D. This measurement is a good indicator of the body's vitamin D stores and is used as a surrogate marker for the biologically active form of vitamin D, 1,25-dihydroxyvitamin D [1,25(OH)2D]. Assessing 25(OH)D levels allows clinicians to evaluate the effectiveness of treatment and make necessary adjustments to achieve therapeutic targets.

**Why Each Wrong Option is Incorrect**
**Option A:** Parathyroid hormone [PTH] levels can be influenced by vitamin D status, but they are not a direct measure of vitamin D stores and are affected by other factors, making them a less reliable indicator of treatment efficacy.
**Option B:** Serum calcium levels can be affected by vitamin D status, but they do not accurately reflect the body's vitamin D stores and are influenced by other factors, such as parathyroid hormone and dietary calcium intake.
**Option C:** 1,25-dihydroxyvitamin D [1,25(OH)2D] is the biologically active form of vitamin D, but measuring its levels directly is not practical due to its short half-life and the need for specialized laboratory techniques.

**Clinical Pearl / High-Yield Fact**
The National Osteoporosis Foundation recommends a 25(OH)D level of at least 30 ng/mL for optimal bone health, with some experts advocating for a target of 40-50 ng/mL.

**Correct Answer:** C. 25-hydroxyvitamin D [25(OH)D]